Formulation, Product and Process Innovation Enabling Next-Gen Therapies

Session details:

Formulation and delivery are no longer downstream considerations—they are critical enablers of therapeutic success. From high-concentration biologics to RNA-based therapies and smart devices, the future of drug development demands early, integrated strategies that optimize stability, usability, and scalability. This panel brings together formulation scientists, delivery innovators, and CMC leaders to explore how cross-functional design is driving the next wave of therapeutic innovation. 

• Formulation–Delivery Synergy: How excipients, viscosity, and molecular properties impact device selection, stability, and pharmacokinetics 
• Advanced Delivery Systems: Harnessing LNPs, polymeric carriers, and micelles for mRNA, siRNA, and complex biologics
• Device-Driven Design: Aligning formulation characteristics with autoinjectors, wearable pumps, and pens for usability and performance
• From Bench to IND: De-risking tech transfer and scale-up through early integration of formulation and delivery decisions